VERA Institutional Ownership

VERA THERAPEUTICS INC

Latest close $30.23 as of Aug 5, 2026

Create account to watch
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices. Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes. Filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro. The overall institutional consensus preview remains public. Compare plans.
Cross-institution intelligence

Institutional Research

Each institution is compared with its own prior filing, then the latest institution-level directions are compared for breadth.

Latest filing Jul 30, 2026
Public consensus preview Reduction leaning 37/100 institutional research score
4 tracked institutions Latest filing Jul 30, 2026

1 reducing across 1 comparable institution.

Accumulating0
Unchanged0
Reducing1
Exited0

The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.

Price context

52-week position is market context and does not change the institutional consensus score.

52-week low$19.07 52-week high$56.05
Latest close $30.23 30.2% through the range

Tracked institutions

Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.

Latest observation Jun 30, 2026
BlackRock Jul 30, 2026 filed
Vanguard Group Mar 27, 2026 filed
Fidelity / FMR Feb 5, 2026 filed
T. Rowe Price Associates May 15, 2026 filed
Detailed institutional research

See what is driving the consensus.

Unlock holder-by-holder changes, ownership history, breadth by period, disclosure timing, and filing-specific signal analysis.

Create free account Compare Investor and Pro

A free account adds watchlists and reveals tracker research gauges. Investor or Pro unlocks the detailed research above.

Beneficial ownership filing history

Showing 3 of 8 parsed filing(s) · 5 older require more history access
Holder Observed / filed Reported change Shares Ownership Observation Filing Latest
BlackRock CIK0002012383 Jun 30, 2026 observed Jul 30, 2026 filed · 30d Schedule 13G amendment Earliest Schedule 13G amendment found 5.3M 12.00% $42.91 $33.05 $30.23
T. Rowe Price Associates CIK0000080255 Mar 31, 2026 observed May 15, 2026 filed · 45d Schedule 13G amendment Reported reduction 4.6M -888.3K 12.00% 0.00 pts $40.23 $37.32 $30.23
Vanguard Group CIK0000102909 Mar 13, 2026 observed Mar 27, 2026 filed · 14d Schedule 13G amendment Earliest Schedule 13G amendment found 11 12.00% $39.96 $38.86 $30.23
Explore more institutional activity

Related research

Crawlable links to other securities with similar institutional consensus or recent multi-institution accumulation.

Similar research strength

UVSP UNIVEST FINANCIAL Corp 37/100 Reduction leaning PD PAGERDUTY INC 37/100 Reduction leaning MLR MILLER INDUSTRIES INC /TN/ 37/100 Reduction leaning SBFG SB FINANCIAL GROUP, INC. 37/100 Reduction leaning

Recent multi-institution accumulation

TVTX Travere Therapeutics, Inc. 2 accumulating Aug 6, 2026 PCVX VAXCYTE INC 2 accumulating Aug 6, 2026 VVX V2X INC 2 accumulating Aug 6, 2026 VSEC VSE CORP 3 accumulating Jul 31, 2026